Dengue Clinical Trial
Official title:
Follow-up the Health Condition , Investigation of the Immuno-regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever Infection
Originally test host's to understand the tracking healthily and immune change of the dengue
fever in Taiwan. Blood drawing 20 c.c for liver examination, kidney and other biochemical
function, analyze host immunity adjusts and controls the gene, and the reciprocation that
may be produced with the virus hepatitis, besides collected 10 c.c urine at the same time.
Urine check is in order to compare acute infect and infected over three month person, the
change of chemical composition.
This plan expect to collect 150 healthy, 150 dengue fever infected and 150 dengue fever
bleed hot or dengue fever shock disease group's patient, goal to understand health state and
immunity of follow-up adjust and control the difference of the gene and the reciprocation
may produce to virus hepatitis of light disease and serious disease.
The dengue fever is an important tropical infectious disease in the south of Taiwan, cause
and threaten of public health at Kaohsiung and Ping-Dong all over the years, this will cause
patient's death, the default of clinical change of dengue fever, acute infect, infect
influence, host immunity adjust and control, and the reciprocation of virus hepatitis, will
be a very urgent in basic research.
Originally test host's to understand the tracking healthily and immune change of the dengue
fever in Taiwan. Blood drawing 20 c.c for liver examination, kidney and other biochemical
function, analyze host immunity adjusts and controls the gene, and the reciprocation that
may be produced with the virus hepatitis, besides collected 10 c.c urine at the same time.
This plan expect to collect 150 healthy, 150 dengue fever infected and 150 dengue fever
bleed hot or dengue fever shock disease group's patient, goal to understand health state and
immunity of follow-up adjust and control the difference of the gene and the reciprocation
may produce to virus hepatitis of light disease and serious disease.
Urine check is in order to compare acute infect and infected over three month person, the
change of chemical composition. The result of study can help doctor to understand the factor
of immune regulation and control of the host and health change after the dengue fever is
infected with, possible reciprocation with virus hepatitis. Researchers have collect 100
dengue fever bleed hot or dengue fever shock syndrome groups of patient, it is estimated
that can collect and expect the case will be counted within two years.
;
Observational Model: Case Control, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05321264 -
Educational Intervention to Promote Control Behaviors and Prevention of Dengue
|
N/A | |
Completed |
NCT01436396 -
Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers
|
Phase 3 | |
Completed |
NCT01391819 -
Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children
|
N/A | |
Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
Completed |
NCT02833584 -
Safety of Paracetamol as Antipyretic in Treatment of Dengue Infection in Adults
|
N/A | |
Completed |
NCT02433652 -
Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2
|
Phase 1 | |
Enrolling by invitation |
NCT02016027 -
Pharmacological Effect of Carica Papaya Leaves Mother Tincture in Healthy Individuals Blood Parameter
|
Phase 1 | |
Completed |
NCT01477671 -
Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children
|
N/A | |
Recruiting |
NCT00377754 -
Prospective Study of Infant Dengue
|
N/A | |
Recruiting |
NCT05919277 -
A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires
|
||
Recruiting |
NCT04582474 -
Demonstration of an Electronic Clinical Decision Support Module for Dengue in Burkina Faso
|
N/A | |
Completed |
NCT01983553 -
Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study
|
||
Completed |
NCT03803618 -
Dengue Effectiveness Study in the Philippines
|
||
Active, not recruiting |
NCT05967455 -
Homologous Re-infection With Dengue 1 or Dengue 3
|
Phase 1 | |
Completed |
NCT03631719 -
Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia
|
||
Recruiting |
NCT02606019 -
The Use of Biomarkers in Predicting Dengue Outcome
|
N/A | |
Completed |
NCT02372175 -
Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain
|
Phase 1 | |
Active, not recruiting |
NCT01696422 -
Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine
|
Phase 2 | |
Completed |
NCT00993447 -
Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America
|
Phase 2 | |
Completed |
NCT00375726 -
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults
|
Phase 1 |